250 Participants NeededMy employer runs this trial
Telitacicept for Sjogren's Syndrome
(UPSTREAM SjD Trial)
Recruiting at 17 trial locations
JS
Overseen ByJeremy Sokolove
Age: 18+
Sex: Any
Trial Phase: Phase 3
Sponsor: Vor Biopharma
Pivotal Trial (Near Approval)This treatment is in the last trial phase before FDA approval
Prior Safety DataThis treatment has passed at least one previous human trial
What You Need to Know Before You Apply
What is the purpose of this trial?
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease (UPSTREAM SjD)
Are You a Good Fit for This Trial?
Inclusion Criteria
I have been diagnosed with primary Sjogren's Syndrome according to the 2016 ACR/EULAR criteria.
I meet other specific requirements listed in the study details.
I am between 18 and 75 years old.
See 2 more
What Are the Treatments Tested in This Trial?
Interventions
- Telitacicept
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Placebo Group
Group I: TelitaciceptExperimental Treatment1 Intervention
Telitacicept
Group II: PlaceboPlacebo Group1 Intervention
Placebo
Find a Clinic Near You
Who Is Running the Clinical Trial?
Vor Biopharma
Lead Sponsor
Trials
3
Recruited
80+
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.